These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3771813)

  • 1. Propranolol for adults with temper outbursts and residual attention deficit disorder.
    Mattes JA
    J Clin Psychopharmacol; 1986 Oct; 6(5):299-302. PubMed ID: 3771813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effectiveness of carbamazepine and propranolol for rage outbursts.
    Mattes JA
    J Neuropsychiatry Clin Neurosci; 1990; 2(2):159-64. PubMed ID: 2136070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attention deficit disorder in children: three clinical variants.
    de Quirós GB; Kinsbourne M; Palmer RL; Rufo DT
    J Dev Behav Pediatr; 1994 Oct; 15(5):311-9. PubMed ID: 7868698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approach to attention deficit disorder in adults.
    Matas M
    Can Fam Physician; 2006 Aug; 52(8):961-4. PubMed ID: 17273498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological treatment of attention deficit disorder, residual type (ADD,RT, "minimal brain dysfunction," "hyperactivity") in adults.
    Wender PH; Wood DR; Reimherr FW
    Psychopharmacol Bull; 1985; 21(2):222-31. PubMed ID: 3923527
    [No Abstract]   [Full Text] [Related]  

  • 7. A family study of patients with temper outbursts.
    Mattes JA; Fink M
    J Psychiatr Res; 1987; 21(3):249-55. PubMed ID: 3681760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Attention-deficit/hyperactivity disorder (ADHS) in adulthood].
    Kordon A; Kahl KG
    Psychother Psychosom Med Psychol; 2004; 54(3-4):124-36. PubMed ID: 15037976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advancing the spontaneous hypertensive rat model of attention deficit/hyperactivity disorder.
    Kantak KM; Singh T; Kerstetter KA; Dembro KA; Mutebi MM; Harvey RC; Deschepper CF; Dwoskin LP
    Behav Neurosci; 2008 Apr; 122(2):340-57. PubMed ID: 18410173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical recognition and management of adult attention deficit hyperactivity disorder.
    Craig C
    Nurse Pract; 1996 Nov; 21(11):101-6, 108. PubMed ID: 8933539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
    Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open-label trial of venlafaxine in adults with attention deficit disorder.
    Adler LA; Resnick S; Kunz M; Devinsky O
    Psychopharmacol Bull; 1995; 31(4):785-8. PubMed ID: 8851654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Lee SI; Hong SD; Kim SY; Kim EJ; Kim JH; Kim JH; Park MK; Park S; Park JH; Oh EY; Lim TS; Cheong S; Cho IH; Choi JW
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):210-6. PubMed ID: 17046131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attention deficit and impulsivity: selecting, shifting, and stopping.
    Kenemans JL; Bekker EM; Lijffijt M; Overtoom CC; Jonkman LM; Verbaten MN
    Int J Psychophysiol; 2005 Oct; 58(1):59-70. PubMed ID: 15950304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder.
    Bangs ME; Hazell P; Danckaerts M; Hoare P; Coghill DR; Wehmeier PM; Williams DW; Moore RJ; Levine L;
    Pediatrics; 2008 Feb; 121(2):e314-20. PubMed ID: 18245404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder.
    Turner DC; Clark L; Dowson J; Robbins TW; Sahakian BJ
    Biol Psychiatry; 2004 May; 55(10):1031-40. PubMed ID: 15121488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attention deficit/hyperactivity disorder--from brain dysfunctions to behaviour.
    Sagvolden T; Sergeant JA
    Behav Brain Res; 1998 Jul; 94(1):1-10. PubMed ID: 9708834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Behavioral and pharmacological studies of juvenile stroke-prone spontaneously hypertensive rats as an animal model of attention-deficit/hyperactivity disorder].
    Ueno K; Togashi H; Yoshioka M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Feb; 23(1):47-55. PubMed ID: 12690641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotine and attention in adult attention deficit hyperactivity disorder (ADHD).
    Conners CK; Levin ED; Sparrow E; Hinton SC; Erhardt D; Meck WH; Rose JE; March J
    Psychopharmacol Bull; 1996; 32(1):67-73. PubMed ID: 8927677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hyperactive behavior in adults; possibly attention deficit/hyperactivity disorder (ADHD)].
    Weisfelt M; Schrier AC; de Leeuw MC
    Ned Tijdschr Geneeskd; 2001 Aug; 145(31):1481-4. PubMed ID: 11512417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.